Danvatirsen
Danvatirsen Uses, Dosage, Side Effects, Food Interaction and all others data.
Danvatirsen is under investigation in clinical trial NCT03334617 (Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy.).
| Trade Name | Danvatirsen |
| Generic | Danvatirsen |
| Danvatirsen Other Names | Danvatirsen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Danvatirsen
